Literature DB >> 6255413

Analysis of the secondary and tertiary structures of Rous sarcoma virus RNA.

J L Darlix, M Schwager, P F Spahr, P A Bromley.   

Abstract

The secondary and tertiary structures of the 35S RNA of Rous Sarcoma virus have been investigated. T1 RNase partial digests have been first resolved into their components by gel electrophoresis under non denaturing conditions and then each component analyzed further by various techniques. More than one hundred structured fragments have thus been isolated and shown to consist of several individual nucleotide sequences located far apart on the genome. On the basis of the results, a cloverleaf model for the structure of RSV 35S RNA is proposed that has implications for the various biological functions of this RNA.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6255413      PMCID： PMC324156          DOI： 10.1093/nar/8.15.3335

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


  23 in total

1.  Stimultaneous purification of Escherichia coli termination factor rho, RNAase III and RNAase H.

Authors:  J L Darlix
Journal:  Eur J Biochem       Date:  1975-02-21

2.  Electron microscope studies of tumor virus RNA.

Authors:  H J Kung; J M Bailey; N Davidson; P K Vogt; M O Nicolson; R M McAllister
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  A physical map of the Rous sarcoma virus genome.

Authors:  J M Coffin; M A Billeter
Journal:  J Mol Biol       Date:  1976-01-25       Impact factor: 5.469

4.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

5.  Nucleotide sequence of the gene coding for the bacteriophage MS2 coat protein.

Authors:  W Min Jou; G Haegeman; M Ysebaert; W Fiers
Journal:  Nature       Date:  1972-05-12       Impact factor: 49.962

6.  A sequence of 50 nucleotides from coliphage R17 RNA.

Authors:  U F Rensing; G G Schoenmakers
Journal:  Eur J Biochem       Date:  1973-02-15

7.  Translation of R-17 RNA fragments.

Authors:  R F Gesteland; P F Spahr
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1969

8.  The reaction of ribonucleic acid with formaldehyde. I. Optical absorbance studies.

Authors:  H Boedtker
Journal:  Biochemistry       Date:  1967-09       Impact factor: 3.162

9.  Preparative two-dimensional polyacrylamide gel electrophoresis of 32 P-labeled RNA.

Authors:  R de Wachter; W Fiers
Journal:  Anal Biochem       Date:  1972-09       Impact factor: 3.365

10.  New procedure for the direct analysis of in vitro reverse transcription of Rous sarcoma virus RNA.

Authors:  J L Darlix; P A Bromley; P F Spahr
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103
View more
  8 in total

1.  A model for the expression of CaMV nucleic acid.

Authors:  R Hull
Journal:  Plant Mol Biol       Date:  1984-05       Impact factor: 4.076

2.  A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro.

Authors:  E Bieth; C Gabus; J L Darlix
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

3.  A retroviral RNA secondary structure required for efficient initiation of reverse transcription.

Authors:  D Cobrinik; L Soskey; J Leis
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

4.  A model structure for Rous sarcoma virus genomic RNA and its implication for various functions of the viral RNA.

Authors:  J L Darlix; P A Bromley; P F Spahr
Journal:  Mol Biol Rep       Date:  1981-05-22       Impact factor: 2.316

5.  Structure-function relationship of Rous sarcoma virus leader RNA.

Authors:  J L Darlix; M Zuker; P F Spahr
Journal:  Nucleic Acids Res       Date:  1982-09-11       Impact factor: 16.971

6.  High spontaneous mutation rate of Rous sarcoma virus demonstrated by direct sequencing of the RNA genome.

Authors:  J L Darlix; P F Spahr
Journal:  Nucleic Acids Res       Date:  1983-09-10       Impact factor: 16.971

7.  Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site.

Authors:  X Li; Y Quan; E J Arts; Z Li; B D Preston; H de Rocquigny; B P Roques; J L Darlix; L Kleiman; M A Parniak; M A Wainberg
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.

Authors:  Yasumasa Iwatani; Denise S B Chan; F Wang; Kristen Stewart Maynard; Wataru Sugiura; Angela M Gronenborn; Ioulia Rouzina; Mark C Williams; Karin Musier-Forsyth; Judith G Levin
Journal:  Nucleic Acids Res       Date:  2007-10-16       Impact factor: 16.971
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.